Swiss healthtech startup Aeon has secured €8.2 million (US$9 million) in seed funding, led by Concentric, to enhance its AI-driven preventive healthcare services, including whole-body MRI scans and genetic testing. The funding will facilitate expansion into Switzerland, Germany, and the UK, with plans for over 10 new locations. Aeon's innovative approach addresses the significant preventive care gap, aiming to reduce chronic disease burdens through comprehensive diagnostics and insurance reimbursement strategies.